0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Non-Invasive Drug Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-28J7712
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non Invasive Drug Delivery Market Insights and Forecast to 2028
BUY CHAPTERS

Non-Invasive Drug Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28J7712
Report
November 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Invasive Drug Delivery - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-Invasive Drug Delivery - Market

Non-Invasive Drug Delivery - Market

The global market for Non-Invasive Drug Delivery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Non-Invasive Drug Delivery by region & country, by Type, and by Application.
The Non-Invasive Drug Delivery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery.
Market Segmentation

Scope of Non-Invasive Drug Delivery - Market Report

Report Metric Details
Report Name Non-Invasive Drug Delivery - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, HNS International, Inc., Inovio Pharmaceuticals, Inc., Medtronic Plc., Novartis AG, PenJet Corporation, PharmaJet, Portal Instruments, ResMed, Sensiron AG, Tandem Diabetes Care, Inc., Teva Pharmaceuticals Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Non-Invasive Drug Delivery manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Non-Invasive Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Non-Invasive Drug Delivery in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Non-Invasive Drug Delivery - Market report?

Ans: The main players in the Non-Invasive Drug Delivery - Market are Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, HNS International, Inc., Inovio Pharmaceuticals, Inc., Medtronic Plc., Novartis AG, PenJet Corporation, PharmaJet, Portal Instruments, ResMed, Sensiron AG, Tandem Diabetes Care, Inc., Teva Pharmaceuticals Industries Ltd.

What are the Application segmentation covered in the Non-Invasive Drug Delivery - Market report?

Ans: The Applications covered in the Non-Invasive Drug Delivery - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Non-Invasive Drug Delivery - Market report?

Ans: The Types covered in the Non-Invasive Drug Delivery - Market report are Artificial Pancreas, Needle Free Injector, Digital Respiratory Devices, Other

Recommended Reports

Drug Delivery Devices

Specialty Therapy Devices

Non-Invasive Solutions

1 Market Overview
1.1 Non-Invasive Drug Delivery Product Introduction
1.2 Global Non-Invasive Drug Delivery Market Size Forecast
1.3 Non-Invasive Drug Delivery Market Trends & Drivers
1.3.1 Non-Invasive Drug Delivery Industry Trends
1.3.2 Non-Invasive Drug Delivery Market Drivers & Opportunity
1.3.3 Non-Invasive Drug Delivery Market Challenges
1.3.4 Non-Invasive Drug Delivery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-Invasive Drug Delivery Players Revenue Ranking (2023)
2.2 Global Non-Invasive Drug Delivery Revenue by Company (2019-2024)
2.3 Key Companies Non-Invasive Drug Delivery Manufacturing Base Distribution and Headquarters
2.4 Key Companies Non-Invasive Drug Delivery Product Offered
2.5 Key Companies Time to Begin Mass Production of Non-Invasive Drug Delivery
2.6 Non-Invasive Drug Delivery Market Competitive Analysis
2.6.1 Non-Invasive Drug Delivery Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Non-Invasive Drug Delivery Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Artificial Pancreas
3.1.2 Needle Free Injector
3.1.3 Digital Respiratory Devices
3.1.4 Other
3.2 Global Non-Invasive Drug Delivery Sales Value by Type
3.2.1 Global Non-Invasive Drug Delivery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-Invasive Drug Delivery Sales Value, by Type (2019-2030)
3.2.3 Global Non-Invasive Drug Delivery Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Non-Invasive Drug Delivery Sales Value by Application
4.2.1 Global Non-Invasive Drug Delivery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-Invasive Drug Delivery Sales Value, by Application (2019-2030)
4.2.3 Global Non-Invasive Drug Delivery Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Non-Invasive Drug Delivery Sales Value by Region
5.1.1 Global Non-Invasive Drug Delivery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-Invasive Drug Delivery Sales Value by Region (2019-2024)
5.1.3 Global Non-Invasive Drug Delivery Sales Value by Region (2025-2030)
5.1.4 Global Non-Invasive Drug Delivery Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Non-Invasive Drug Delivery Sales Value, 2019-2030
5.2.2 North America Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Non-Invasive Drug Delivery Sales Value, 2019-2030
5.3.2 Europe Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Non-Invasive Drug Delivery Sales Value, 2019-2030
5.4.2 Asia Pacific Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Non-Invasive Drug Delivery Sales Value, 2019-2030
5.5.2 South America Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Non-Invasive Drug Delivery Sales Value, 2019-2030
5.6.2 Middle East & Africa Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-Invasive Drug Delivery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-Invasive Drug Delivery Sales Value
6.3 United States
6.3.1 United States Non-Invasive Drug Delivery Sales Value, 2019-2030
6.3.2 United States Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-Invasive Drug Delivery Sales Value, 2019-2030
6.4.2 Europe Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-Invasive Drug Delivery Sales Value, 2019-2030
6.5.2 China Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-Invasive Drug Delivery Sales Value, 2019-2030
6.6.2 Japan Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-Invasive Drug Delivery Sales Value, 2019-2030
6.7.2 South Korea Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-Invasive Drug Delivery Sales Value, 2019-2030
6.8.2 Southeast Asia Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-Invasive Drug Delivery Sales Value, 2019-2030
6.9.2 India Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-Invasive Drug Delivery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Adherium Limited
7.1.1 Adherium Limited Profile
7.1.2 Adherium Limited Main Business
7.1.3 Adherium Limited Non-Invasive Drug Delivery Products, Services and Solutions
7.1.4 Adherium Limited Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.1.5 Adherium Limited Recent Developments
7.2 Capsule Technologies, Inc.
7.2.1 Capsule Technologies, Inc. Profile
7.2.2 Capsule Technologies, Inc. Main Business
7.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
7.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.2.5 Capsule Technologies, Inc. Recent Developments
7.3 Crossject S.A.
7.3.1 Crossject S.A. Profile
7.3.2 Crossject S.A. Main Business
7.3.3 Crossject S.A. Non-Invasive Drug Delivery Products, Services and Solutions
7.3.4 Crossject S.A. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.3.5 Diabeloop SA Recent Developments
7.4 Diabeloop SA
7.4.1 Diabeloop SA Profile
7.4.2 Diabeloop SA Main Business
7.4.3 Diabeloop SA Non-Invasive Drug Delivery Products, Services and Solutions
7.4.4 Diabeloop SA Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.4.5 Diabeloop SA Recent Developments
7.5 HNS International, Inc.
7.5.1 HNS International, Inc. Profile
7.5.2 HNS International, Inc. Main Business
7.5.3 HNS International, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
7.5.4 HNS International, Inc. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.5.5 HNS International, Inc. Recent Developments
7.6 Inovio Pharmaceuticals, Inc.
7.6.1 Inovio Pharmaceuticals, Inc. Profile
7.6.2 Inovio Pharmaceuticals, Inc. Main Business
7.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
7.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.6.5 Inovio Pharmaceuticals, Inc. Recent Developments
7.7 Medtronic Plc.
7.7.1 Medtronic Plc. Profile
7.7.2 Medtronic Plc. Main Business
7.7.3 Medtronic Plc. Non-Invasive Drug Delivery Products, Services and Solutions
7.7.4 Medtronic Plc. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.7.5 Medtronic Plc. Recent Developments
7.8 Novartis AG
7.8.1 Novartis AG Profile
7.8.2 Novartis AG Main Business
7.8.3 Novartis AG Non-Invasive Drug Delivery Products, Services and Solutions
7.8.4 Novartis AG Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.8.5 Novartis AG Recent Developments
7.9 PenJet Corporation
7.9.1 PenJet Corporation Profile
7.9.2 PenJet Corporation Main Business
7.9.3 PenJet Corporation Non-Invasive Drug Delivery Products, Services and Solutions
7.9.4 PenJet Corporation Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.9.5 PenJet Corporation Recent Developments
7.10 PharmaJet
7.10.1 PharmaJet Profile
7.10.2 PharmaJet Main Business
7.10.3 PharmaJet Non-Invasive Drug Delivery Products, Services and Solutions
7.10.4 PharmaJet Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.10.5 PharmaJet Recent Developments
7.11 Portal Instruments
7.11.1 Portal Instruments Profile
7.11.2 Portal Instruments Main Business
7.11.3 Portal Instruments Non-Invasive Drug Delivery Products, Services and Solutions
7.11.4 Portal Instruments Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.11.5 Portal Instruments Recent Developments
7.12 ResMed
7.12.1 ResMed Profile
7.12.2 ResMed Main Business
7.12.3 ResMed Non-Invasive Drug Delivery Products, Services and Solutions
7.12.4 ResMed Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.12.5 ResMed Recent Developments
7.13 Sensiron AG
7.13.1 Sensiron AG Profile
7.13.2 Sensiron AG Main Business
7.13.3 Sensiron AG Non-Invasive Drug Delivery Products, Services and Solutions
7.13.4 Sensiron AG Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.13.5 Sensiron AG Recent Developments
7.14 Tandem Diabetes Care, Inc.
7.14.1 Tandem Diabetes Care, Inc. Profile
7.14.2 Tandem Diabetes Care, Inc. Main Business
7.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
7.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.14.5 Tandem Diabetes Care, Inc. Recent Developments
7.15 Teva Pharmaceuticals Industries Ltd.
7.15.1 Teva Pharmaceuticals Industries Ltd. Profile
7.15.2 Teva Pharmaceuticals Industries Ltd. Main Business
7.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Products, Services and Solutions
7.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue (US$ Million) & (2019-2024)
7.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Non-Invasive Drug Delivery Industrial Chain
8.2 Non-Invasive Drug Delivery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-Invasive Drug Delivery Sales Model
8.5.2 Sales Channel
8.5.3 Non-Invasive Drug Delivery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Non-Invasive Drug Delivery Market Trends
    Table 2. Non-Invasive Drug Delivery Market Drivers & Opportunity
    Table 3. Non-Invasive Drug Delivery Market Challenges
    Table 4. Non-Invasive Drug Delivery Market Restraints
    Table 5. Global Non-Invasive Drug Delivery Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Non-Invasive Drug Delivery Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Non-Invasive Drug Delivery Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Non-Invasive Drug Delivery Product Type
    Table 9. Key Companies Time to Begin Mass Production of Non-Invasive Drug Delivery
    Table 10. Global Non-Invasive Drug Delivery Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Non-Invasive Drug Delivery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Non-Invasive Drug Delivery Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Non-Invasive Drug Delivery Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Non-Invasive Drug Delivery Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Non-Invasive Drug Delivery Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Non-Invasive Drug Delivery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Non-Invasive Drug Delivery Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Non-Invasive Drug Delivery Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Non-Invasive Drug Delivery Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Non-Invasive Drug Delivery Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Non-Invasive Drug Delivery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Non-Invasive Drug Delivery Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Non-Invasive Drug Delivery Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Non-Invasive Drug Delivery Sales Value by Region (2019-2024) & (%)
    Table 27. Global Non-Invasive Drug Delivery Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Non-Invasive Drug Delivery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Non-Invasive Drug Delivery Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Non-Invasive Drug Delivery Sales Value, (2025-2030) & (US$ Million)
    Table 31. Adherium Limited Basic Information List
    Table 32. Adherium Limited Description and Business Overview
    Table 33. Adherium Limited Non-Invasive Drug Delivery Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Adherium Limited (2019-2024)
    Table 35. Adherium Limited Recent Developments
    Table 36. Capsule Technologies, Inc. Basic Information List
    Table 37. Capsule Technologies, Inc. Description and Business Overview
    Table 38. Capsule Technologies, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Capsule Technologies, Inc. (2019-2024)
    Table 40. Capsule Technologies, Inc. Recent Developments
    Table 41. Crossject S.A. Basic Information List
    Table 42. Crossject S.A. Description and Business Overview
    Table 43. Crossject S.A. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Crossject S.A. (2019-2024)
    Table 45. Crossject S.A. Recent Developments
    Table 46. Diabeloop SA Basic Information List
    Table 47. Diabeloop SA Description and Business Overview
    Table 48. Diabeloop SA Non-Invasive Drug Delivery Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Diabeloop SA (2019-2024)
    Table 50. Diabeloop SA Recent Developments
    Table 51. HNS International, Inc. Basic Information List
    Table 52. HNS International, Inc. Description and Business Overview
    Table 53. HNS International, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of HNS International, Inc. (2019-2024)
    Table 55. HNS International, Inc. Recent Developments
    Table 56. Inovio Pharmaceuticals, Inc. Basic Information List
    Table 57. Inovio Pharmaceuticals, Inc. Description and Business Overview
    Table 58. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Inovio Pharmaceuticals, Inc. (2019-2024)
    Table 60. Inovio Pharmaceuticals, Inc. Recent Developments
    Table 61. Medtronic Plc. Basic Information List
    Table 62. Medtronic Plc. Description and Business Overview
    Table 63. Medtronic Plc. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Medtronic Plc. (2019-2024)
    Table 65. Medtronic Plc. Recent Developments
    Table 66. Novartis AG Basic Information List
    Table 67. Novartis AG Description and Business Overview
    Table 68. Novartis AG Non-Invasive Drug Delivery Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Novartis AG (2019-2024)
    Table 70. Novartis AG Recent Developments
    Table 71. PenJet Corporation Basic Information List
    Table 72. PenJet Corporation Description and Business Overview
    Table 73. PenJet Corporation Non-Invasive Drug Delivery Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of PenJet Corporation (2019-2024)
    Table 75. PenJet Corporation Recent Developments
    Table 76. PharmaJet Basic Information List
    Table 77. PharmaJet Description and Business Overview
    Table 78. PharmaJet Non-Invasive Drug Delivery Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of PharmaJet (2019-2024)
    Table 80. PharmaJet Recent Developments
    Table 81. Portal Instruments Basic Information List
    Table 82. Portal Instruments Description and Business Overview
    Table 83. Portal Instruments Non-Invasive Drug Delivery Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Portal Instruments (2019-2024)
    Table 85. Portal Instruments Recent Developments
    Table 86. ResMed Basic Information List
    Table 87. ResMed Description and Business Overview
    Table 88. ResMed Non-Invasive Drug Delivery Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of ResMed (2019-2024)
    Table 90. ResMed Recent Developments
    Table 91. Sensiron AG Basic Information List
    Table 92. Sensiron AG Description and Business Overview
    Table 93. Sensiron AG Non-Invasive Drug Delivery Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Sensiron AG (2019-2024)
    Table 95. Sensiron AG Recent Developments
    Table 96. Tandem Diabetes Care, Inc. Basic Information List
    Table 97. Tandem Diabetes Care, Inc. Description and Business Overview
    Table 98. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Tandem Diabetes Care, Inc. (2019-2024)
    Table 100. Tandem Diabetes Care, Inc. Recent Developments
    Table 101. Teva Pharmaceuticals Industries Ltd. Basic Information List
    Table 102. Teva Pharmaceuticals Industries Ltd. Description and Business Overview
    Table 103. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Non-Invasive Drug Delivery Business of Teva Pharmaceuticals Industries Ltd. (2019-2024)
    Table 105. Teva Pharmaceuticals Industries Ltd. Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Non-Invasive Drug Delivery Downstream Customers
    Table 109. Non-Invasive Drug Delivery Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Non-Invasive Drug Delivery Product Picture
    Figure 2. Global Non-Invasive Drug Delivery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 4. Non-Invasive Drug Delivery Report Years Considered
    Figure 5. Global Non-Invasive Drug Delivery Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Invasive Drug Delivery Revenue in 2023
    Figure 7. Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Artificial Pancreas Picture
    Figure 9. Needle Free Injector Picture
    Figure 10. Digital Respiratory Devices Picture
    Figure 11. Other Picture
    Figure 12. Global Non-Invasive Drug Delivery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Non-Invasive Drug Delivery Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinic
    Figure 16. Product Picture of Other
    Figure 17. Global Non-Invasive Drug Delivery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Non-Invasive Drug Delivery Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Non-Invasive Drug Delivery Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Non-Invasive Drug Delivery Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Non-Invasive Drug Delivery Sales Value (%), (2019-2030)
    Figure 30. United States Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Non-Invasive Drug Delivery Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Non-Invasive Drug Delivery Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Non-Invasive Drug Delivery Sales Value by Application (%), 2023 VS 2030
    Figure 51. Non-Invasive Drug Delivery Industrial Chain
    Figure 52. Non-Invasive Drug Delivery Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart